Welcome to our dedicated page for AMERICAN HEALTHCARE REIT SEC filings (Ticker: AHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Healthcare REIT filings document the reporting framework for a NYSE-listed healthcare REIT with common stock and an operating partnership. Recent 8-K reports furnish earnings releases, financial-position updates, supplemental operating data, distribution authorizations and Regulation FD materials tied to the company's real estate portfolio and segment performance.
Other filings cover material financing arrangements, including credit-facility amendments and an at-the-market equity offering program, as well as proxy disclosures on board governance, executive compensation and stockholder voting matters. Leadership-transition reports and related compensatory arrangements are documented through Form 8-K and amended Form 8-K disclosures.
American Healthcare REIT (NYSE:AHR) filed an 8-K disclosing results from its June 25, 2025 Annual Meeting.
- Nine directors were re-elected for one-year terms ending in 2026.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2025 (138.4 M for / 1.1 M against).
- Say-on-pay for 2024 executive compensation passed (109.3 M for / 7.5 M against).
- The 2025 Manager Equity Plan was approved (112.6 M for / 4.3 M against).
No other matters were brought to a vote.
On June 20, 2025, American Healthcare REIT, Inc. (NYSE: AHR) filed a Form 8-K to announce its second-quarter 2025 cash distribution.
The board authorized a quarterly dividend of $0.25 per common share, equal to an annualized rate of $1.00. Shareholders of record at the close of business on June 30, 2025, will receive the payment on or about July 18, 2025, funded solely from legally available funds.
No additional financial results, transactions, or strategic updates were disclosed in this report.